Roche Holding AG
- Country
- ๐จ๐ญSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)
- Conditions
- Anemia, Kidney Disease, Chronic
- First Posted Date
- 2011-06-23
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 780
- Registration Number
- NCT01379963
- Locations
- ๐ฌ๐ท
Pantokrator Private Clinic; Nephrology, Athens, Greece
๐ฌ๐ทGeneral Hospital of Artas; Nephrology, Arta, Greece
๐ฌ๐ทKyanos Stavros Private Hospital; Nephrologic Clinic, Athens, Greece
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)
- First Posted Date
- 2011-06-23
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 50
- Registration Number
- NCT01378962
- Locations
- ๐ฎ๐น
Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia, Rozzano, Lombardia, Italy
๐ฎ๐นIstituto Regina Elena; Oncologia Medica A, Roma, Lazio, Italy
๐ฎ๐นA.O. Universitaria Policlinico Di Modena; Ematologia, Modena, Emilia-Romagna, Italy
A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases
- First Posted Date
- 2011-06-23
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 146
- Registration Number
- NCT01378975
A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients
- Conditions
- Kidney Transplantation, Cytomegalovirus Infections
- Interventions
- First Posted Date
- 2011-06-20
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 57
- Registration Number
- NCT01376804
- Locations
- ๐ฒ๐ฝ
Instituto Mexicano de Transplantes, Cuernavaca, Mexico
๐ฆ๐บRoyal Children'S Hospital; Department of Nephrology, Parkville, Victoria, Australia
๐บ๐ธUCLA Center For Health Sciences; Division of Pediatric Nephrology, Los angeles, Louisiana, United States
An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2011-06-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 197
- Registration Number
- NCT01375478
Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
- First Posted Date
- 2011-06-15
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 168
- Registration Number
- NCT01374321
- Locations
- ๐ฉ๐ฐ
Aarhus University Hospital, Aalborg, Denmark
๐ฉ๐ฐOdense University Hospital, Odense, Denmark
๐ซ๐ทHรดpital La Timone, Marseille, France
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations
- Conditions
- Non-Squamous Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 6
- Registration Number
- NCT01372384
A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C
- Conditions
- Hepatitis C, Chronic, Healthy Volunteer
- Interventions
- Drug: placebo
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 42
- Registration Number
- NCT01371162
A Pharmacokinetic Study of RO4917523 in Healthy Japanese and Caucasian Subjects
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 42
- Registration Number
- NCT01368926
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2019-06-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1232
- Registration Number
- NCT01367665
- Locations
- ๐ฆ๐บ
Premier Specialists, Kogarah, New South Wales, Australia
๐ฆ๐ทInst. de Oncologia Angel H. Roffo ; Servicio de Oncologia, Buenos Aires, Argentina
๐ฆ๐บSkin and Cancer Foundation Australia, Westmead, New South Wales, Australia